Clinical evaluation of intravenous minocycline
- PMID: 858651
Item in Clipboard
Clinical evaluation of intravenous minocycline
Int J Clin Pharmacol Biopharm.
1977 Apr.
Abstract
24 patients with severe infections were treated with intravenous minocycline 100 mg every 12 hours. Average blood levels were within therapeutic ranges during the first 12 hours after the initial dose. Determination of efficacy of therapy in 23 of the patients who were evaluable showed that clinical and bacteriological results were satisfactory in 20 patients, unsatisfactory in 2, and questionable in 1. One patient developed a fatal secondary infection which may have been related to prior therapy with minocycline. No toxicities or side-effects were observed.
Similar articles
-
[Clinical and bacteriological evaluation of minocycline in mucoviscidosis in children].Poumon Coeur. 1974;30(5):375-82. Poumon Coeur. 1974. PMID: 4469905 French. No abstract available.
-
[Clinical study of intravenous minocycline in the treatment of urinary infections].Acta Urol Belg. 1977 Jul;45(3):293-7. Acta Urol Belg. 1977. PMID: 899984 French. No abstract available.
-
Comparative clinical study of doxycycline and minocycline.Int J Clin Pharmacol Biopharm. 1975 Jan;11(1):19-26. Int J Clin Pharmacol Biopharm. 1975. PMID: 1097343 Clinical Trial.
-
Second-generation tetracyclines, a dermatologic overview: clinical uses and pharmacology.Cutis. 1991 Nov;48(5):411-7. Cutis. 1991. PMID: 1764965 Review.
-
Glycylcyclines: a new generation of tetracyclines.J Antimicrob Chemother. 1995 Apr;35(4):449-52. doi: 10.1093/jac/35.4.449. J Antimicrob Chemother. 1995. PMID: 7628979 Review. No abstract available.
Cited by
-
Use of Oral Tetracyclines in the Treatment of Adult Patients with Community-Acquired Bacterial Pneumonia: A Literature Review on the Often-Overlooked Antibiotic Class.Antibiotics (Basel). 2020 Dec 14;9(12):905. doi: 10.3390/antibiotics9120905. Antibiotics (Basel). 2020. PMID: 33327437 Free PMC article. Review.
-
Minocycline as A Substitute for Doxycycline in Targeted Scenarios: A Systematic Review.Open Forum Infect Dis. 2015 Nov 25;2(4):ofv178. doi: 10.1093/ofid/ofv178. eCollection 2015 Dec. Open Forum Infect Dis. 2015. PMID: 26719847 Free PMC article. Review.
-
Role of newer and re-emerging older agents in the treatment of infections caused by carbapenem-resistant Enterobacteriaceae.Virulence. 2017 May 19;8(4):403-416. doi: 10.1080/21505594.2016.1207834. Epub 2016 Jul 6. Virulence. 2017. PMID: 27384881 Free PMC article. Review.
-
Clinical pharmacokinetics of doxycycline and minocycline.Clin Pharmacokinet. 1988 Dec;15(6):355-66. doi: 10.2165/00003088-198815060-00001. Clin Pharmacokinet. 1988. PMID: 3072140 Review.